Vimarsana
Biggest News Aggregation in the World

Page 21 - Presentation Details News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentation Details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentation Details Today - Breaking & Trending Today

Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zet - Vimarsana News

Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zet

Zetomipzomib added to stable background therapy reduced proteinuria by 50% or greater (ORR) in 11 of 17 patients (64.7%) reaching end of treatment at Week 25. This benefit occurred with a 53% mean reduction of background corticosteroid use.ORRs increased to 94.1% at Week 29 and 88.2% at Week 37 during the safety fol...

Researchers to Present Proof-of-Concept Liver Cancer Detection Data Using the DELFI Platform at AASLD The Liver Meeting® 2022 - Vimarsana News

Researchers to Present Proof-of-Concept Liver Cancer Detection Data Using the DELFI Platform at AASLD The Liver Meeting® 2022

/PRNewswire/ -- Researchers using the DELFI platform, a technology for a new class of high performance, accessible liquid biopsy tests being commercialized by...

Exscientia plc: Exscientia Presents Novel Patient Stratification and Biomarker Data for GTAEXS-617 at the 34th EORTC-NCI-AACR Annual Symposium - Vimarsana News

Exscientia plc: Exscientia Presents Novel Patient Stratification and Biomarker Data for GTAEXS-617 at the 34th EORTC-NCI-AACR Annual Symposium

Combines precision oncology platform with single-cell sequencing and transcriptomics with aim to select patients most likely to benefit from GTAEXS-617 therapy Confirmed and identified CDK7-specific

ESSA Pharma Presents Preclinical Data for its First Generation Androgen Receptor N-Terminal Domain Degrader at the 34th EORTC-NCI-AACR Symposium - Vimarsana News

ESSA Pharma Presents Preclinical Data for its First Generation Androgen Receptor N-Terminal Domain Degrader at the 34th EORTC-NCI-AACR Symposium

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Oct. 26, 2022 /PRNewswire/ - ESSA Pharma Inc. ('ESSA', or the 'Company') (NASDAQ: EPIX), a ...

Hillman Sets Third Quarter 2022 Earnings Release and Results Presentation Date - Vimarsana News

Hillman Sets Third Quarter 2022 Earnings Release and Results Presentation Date

CINCINNATI, Oct. 13, 2022 -- Hillman Solutions Corp. , a leading provider of hardware products and merchandising solutions, plans to host a conference call to discuss its results for the... | October 13, 2022